Changjin Ji

Title: Changjin Ji: Innovator in Benzazepine Compounds

Introduction

Changjin Ji is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his work on benzazepine compounds. His innovative approach has led to advancements in treatments for various diseases.

Latest Patents

Changjin Ji holds 1 patent for his invention titled "Benzazepine compounds, preparation method therefor and pharmaceutical use thereof." This patent focuses on a compound represented by formula II-1 or formula VIII-1. The invention includes a pharmaceutical composition containing these compounds and outlines their pharmaceutical uses. Specifically, the benzazepine compounds can be utilized for treating diseases associated with vasopressin receptors, including hypertension and heart disease.

Career Highlights

Throughout his career, Changjin Ji has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Shanghai Senhui Medicine Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd. His work in these organizations has contributed to the development of innovative medical solutions.

Collaborations

Changjin Ji has collaborated with several professionals in his field, including Lingjian Zhu and Jianyu Shi. These collaborations have fostered a productive environment for research and development in pharmaceuticals.

Conclusion

Changjin Ji's contributions to the field of pharmaceuticals, particularly through his patent on benzazepine compounds, highlight his role as an innovator. His work continues to impact the treatment of significant health issues, showcasing the importance of innovation in medicine.